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Abstract. Advances in the understanding of a class of
Ca2+-binding proteins usually referred to as “Ca2+
buffers” are reported. Proteins historically embraced
within this group include parvalbumins (a and b),
calbindin-D9k, calbindin-D28k and calretinin. Within
the last few years a wealth of data has accumulated
that allow a better understanding of the functions of
particular family members of the >240 identified EF-
hand Ca2+-binding proteins encoded by the human
genome. Studies often involving transgenic animal
models have revealed that they exert their specific
functions within an intricate network consisting of
many proteins and cellular mechanisms involved in
Ca2+ signaling and Ca2+ homeostasis, and are thus an
essential part of the Ca2+ homeostasome. Recent
results indicate that calbindin-D28k, possibly also
calretinin and oncomodulin, the mammalian b par-
valbumin, might have additional Ca2+ sensor func-
tions, leaving parvalbumin and calbindin-D9k as the
only “pure” Ca2+ buffers.
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Introduction and “family relations”: Ca2+-binding
proteins, EF hands, parvalbumin, calbindin-D9k,
calbindin-D28k and calretinin
More than 50 years ago the first Ca2+-binding protein
(CaBP) of the EF-hand family was named parvalbu-
min (PV), based on its small size (parvus= small) and
its albumin-like solubility [1]. The proteinwas isolated
from carp muscle, where it is expressed at millimolar
levels, and this preparation was used to obtain protein
crystals that allowed the X-ray structure of the EF-
hand domain to be deduced [2]. In general, an EF-
hand domain consists of 29–30 amino acids: an a-
helix, followed by a highly conserved stretch of 12
amino acids involved in chelating the Ca2+ ion and,
finally, a second a-helix oriented approximately
perpendicular to the first one. In the structure of PV,
three such motifs, comprising six helical structures
named A–F are present, and the X-ray structure of
the most C-terminal motif, E-helix–Ca2+-binding
loop–F-helix, led to the name EF domain. Based on
the fact that this structuralmotif can be represented by
the index finger and the thumb of the right hand, while
the bent middle finger represents the Ca2+-binding
loop, this structure is commonly referred to as an EF-
hand domain (Fig. 1). Around the same time, two
other family members were discovered by their ability
to bind Ca2+ ions and by their expression being
regulated by vitamin D: calbindin-D28k (CB-D28k)
was first observed in the chicken duodenalmucosa [3],
and supplying vitamin D to vitamin D-deficient rats
induced a protein in the intestinal mucosa [4], later
identified as calbindin-D9k (CB-D9k). Their names
thus reflect the fact that they are proteins capable of
binding Ca2+, are induced by vitamin D and have
apparent molecular masses of 28 and 9 kDa, respec-
tively, as determined by denaturing SDS-polyacryla-
mide gel electrophoresis. Despite their similar names,
they belong to entirely different subfamilies of EF-
hand proteins and thus share little sequence homol-
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ogy. CB-D28k (human gene symbol:CALB1) belongs
together with calretinin (CR; CALB2) and secreta-
gogin (SCGN) to theCALB family of proteins with six
EF-hand domains, whereas CB-D9k is a member of
the large S100 family (human gene symbol: S100G ;
for the classification, see [5] and for a recent review on
the S100 family, see [6]). CR was initially identified as
a protein band of 29 kDa present on Western blots
using rat brain extracts that cross-reacted with an anti-
CB-D28k antibody [7]. Based on the high homology
with CB-D28k, also at the mRNA level, probing of a
chick retina cDNA library under low-stringency
hybridization conditions yielded clones containing
the partial sequence of another protein that was
named calretinin based on its origin (retina) of first
detection and the close resemblance to CB-D28k [8].
The prototypical Ca2+ sensor calmodulin (CaM) was
initially identified in 1970 as a protein, which activates
cyclic nucleotide phosphodiesterase (for a review on
early studies on CaM, see [9]). As more and more
sequences from EF-hand proteins emerged, it was
mainly Kretsinger and co-workers that specialized in
categorizing family members according to sequence
features. Their findings have been published since
1980 [10] and the latest classification dates from 1998
[5].Analysis of the entire human genome has revealed
242 proteins containing EF-hand domains [11] and
more than 600 have been identified altogether, from
many different species [12]. Thus, the family may be
considered as consisting of a finite known number of
proteins, at least in humans and when applying the
well-accepted search criteria of the conserved resi-
dues X, Y, Z, -Y, -X, -Z (for details, see Fig. 1). Besides
the immunoglobulin superfamily, the EF-hand family
of CaBPs is among the largest family containing a
single motif. In general, EF-hand proteins have an
even number of domains (2, 4, 6, 8) organized in pairs,
but in mammals no EF-hand proteins with more than
six domains have yet been detected. Few exceptions
exist with proteins having an odd number of EF-hand
domains, most notably PVs (a and b lineage, see
below) and the family of penta-EF-hand proteins [13].
Knockout (KO) mice have been generated for the
four proteins PV, CB-D9k, CB-D28k and CR that are
the main focus of this review (Table 1) and this has
helped in elucidating the function(s).Results obtained
with these animals are described in the following
sections.
Ca2+ sensors vs Ca2+ buffers
Based on several characteristic features, EF-hand
proteins are typically either classified as Ca2+ sensors
or Ca2+ buffers [14, 15], but based on most recent
results, the distinction between the two groups is
starting to blur. A typical hallmark for sensors is their
relatively large Ca2+-dependent conformational
changes often accompanied by exposure of hydro-
phobic surfaces allowing the interaction with specific
ligands and subsequent regulation of downstream
effectors (for a review, see [14]). The best-studied
example of a Ca2+ sensor is the ubiquitously expressed
CaM and still today, more CaM-dependent functions
as well as CaM-modulated targets are being discov-
ered (for recent reviews on CaM function, see [16,
17]). On the other hand, the 15NMR relaxation studies
on the typical buffer PV revealed the solution
structure to be relatively rigid [18], and both Ca2+-
Figure 1. EF-hand domain motif. (A) The three-dimensional
structure of the EF-hand motif can be visualized by the right
hand: the index finger represents the E-helix (residues 1–10), the
bent middle finger stands for the 12 amino acids of the canonical
Ca2+-binding loop (10–21), and the thumb signifies the F-helix
(19–29). The seven oxygen ligands coordinating the Ca2+ ion are
located at the seven corners of a pentagonal bipyramid (modified
from [25]). (B) X-ray structure from the EF-domain of carp
parvalbumin (modified from [2]). (C) The consensus sequence of
the EF-handCa2+ -binding loop of 12 amino acids (boxed). X, Y, Z,
and -Z are side-chain oxygen ligands, * (also termed -Y) indicates
the backbone carbonyl ligand, and -X is a water ligand that is
hydrogen-bonded to a loop residue. In position 8 (I) Ile, Val and
Leu are themost common residues. At positionsX and -Z,Asp and
Glu are generally present, respectively; “.” denotes any amino acid.
Amino acids at positions 1, 3, 5, 6, 8 and 12 are the most highly
conserved residues, in particular the ones shaded in gray. A
comprehensive review on the structures andmetal-binding proper-
ties of EF-hand domains has been published recently [240]. Data
taken from [227] and PROSITE (http://www.expasy.ch/cgi-bin/
nicedoc.pl?PDOC00018).
2
ht
tp
://
do
c.
re
ro
.c
h
Table 1. Transgenic mouse strains with altered Ca2+ buffer expression.
Protein (mouse gene name)
[references]
Comments/ initial reported phenotype
Parvalbumin a (Pvalb) [61, 65, 68] Constitutive KO. The muscle phenotype was first reported: changes in the dynamics of Ca2+
transients, i.e. , a slower initial decay in Ca2+ leads to a prolongation of the time required to attain
peak twitch tension and to an extension of the half-relaxation time. In the brain, by delaying the
buildup of residual Ca2+ in presynaptic terminals, PVmodulates short-term synaptic plasticity, i.e. , it
attenuates facilitation between stellate/basket cells and Purkinje cells as well as between PV-ir
interneurons and hippocampal pyramidal cells.
Parvalbumin b (Ocm) Not available at the time.
Calbindin-D28k (Calb1)
[127]
Constitutive KO. Initial reported phenotype includes impaired motor coordination and changes in
the Ca2+ signaling in Purkinje cell dendrites.
Calbindin-D28k (Calb1) [147, 148,
186]
Purkinje cell-specific KO. A similar impairment in motor coordination is observed as in the
constitutive KOs indicating that cerebellar CB-D28k expression is responsible for the observed
phenotype. Albeit changes in the time course and amplitude of fast Ca2+ transients after parallel or
climbing fiber stimulation, no alterations in delayed metabotropic glutamate receptor-mediated
Ca2+ transients and in LTD are observed.
Calretinin (Calb2) [74, 183, 184] Constitutive KO. Basal synaptic transmission between the perforant pathway and dentate gyrus
granule cells as well as at the Schaffer commissural input to CA1 pyramidal neurons is normal, yet
LTP is impaired in the dentate gyrus and CR-/- mice show amild impairment in motor coordination.
In the cerebellum, excitability of granule cells is increased leading to an increase in Purkinje cell
firing and synchrony and the occurrence of fast 160-Hz oscillation. CR-/- mice show a mild
impairment in motor coordination.
Calretinin (Calb2) [188] Selective expression of CR only in cerebellar granule cells, no CR expression in all other neurons. In
alert mice, granule cell excitability and Purkinje cell firing behavior is normal, and the 160-Hz
oscillations observed in constitutive CR-/- mice do not occur. With that, the motor phenotype is
rescued and these mice show normal motor coordination.
Calbindin-D9k (S100 g) [166] Constitutive KO. No overt phenotype with respect to Ca2+ homeostasis is observed likely due to
compensatory molecular regulation mechanisms. An up-regulation of intestinal TRPV6 and
PMCA1b during preweaning and renal Ca2+ transporters in adultsmay be responsible for essentially
normal Ca2+ homeostasis.
Calbindin-D9k (S100 g) [164, 165] A frame shift deletion in the S100G gene in the ES cell line E14.1 leads to a constitutional knockout.
No evident phenotype with respect to viability, reproduction and serum Ca2+ levels is seen and also
Ca2+ absorption from the intestine in response to D3 is normal.
TRPV6 (Trpv6)  Calbindin-D9k
(S100 g) [167]
Constitutive KO by breeding of the two single KO strains. As in single KOmice TRPV6-/- and CB-
D9k-/-, serum Ca2+ levels are normal, but in the absence of functional TRPV6, PTH levels are
increased. Under low dietary calcium conditions, Ca2+ transport in the duodenum is less increased
than in WT mice, but D3 administration to vitamin D-deficient KO (TRPV6, CB-D9k) and WT
significantly increases duodenal Ca2+ transport, implying that active intestinal Ca2+ transport can
occur in the absence of TRPV6, CB-D9k or both.
TRPV5 (Trpv5)  Calbindin-D28k
(Calb1) [162]
Constitutive KO by breeding of the two single KO strains. TRPV5-/- CB-D28K-/- mice show
hypercalciuria, both under high or low calcium diets, as also seen in TRPV5-/-, but not CB-D28k-/-
mice. In the absence of TRPV5, CB-D9k is up-regulated in the kidney and results in intestinal Ca2+
hyperabsorption due to elevated CB-D9k and TRPV6 expression levels. These effects are not
present in single KO CB-D28k-/- mice.
Parvalbumin (Pvalb) 
Calbindin-D28k (Calb1) [76, 213]
Constitutive KO by breeding of the two single KO strains. Purkinje cell dendritic spines of double
KOmice are longer and both spine surface and volume are larger.An attenuated effect is also seen in
CB-D28k-/-, but not in PV-/- mice. Alert mice show 160-Hz oscillations in the absence of one or the
other protein and alterations in Purkinje cell firing properties, the biggest differences compared to
WT mice are seen when both proteins are absent.
Parvalbumin (Pvalb) 
Calretinin (Calb2) [230]
Constitutive KO by breeding of the two single KO strains. Epileptogenesis using a kainate model of
mesial temporal lobe epilepsy and also long-term seizure-related alterations of the cytoarchitecture
of the hippocampal formation are not different compared to WT mice.
Calbindin-D28k (Calb1) 
Calretinin (Calb2) [73]
Constitutive KO by breeding of the two single KO strains. Alterations in Purkinje cell firing
properties, but not their intrinsic somatic excitability; cerebellar oscillations are observed that are
slightly different than the ones seen in single KO mice.
Calbindin-D28k (Calb1) 
Calretinin (Calb2) x
Parvalbumin (Pvalb)
ConstitutiveKObybreedingof the three singleKOstrains. The hearingphenotype is currently being
investigated, since all three proteins are expressed in inner hair cells.
Thy-PV [218] Ectopic expression of PV under the control of the Thy-1 promoter. Ca2+ transients elicited by
activation of Ca2+-permeable AMPA receptors with kainic acid in cultured motor neurons are
attenuated in Thy-PV mice and partially protect these neurons from cell death.
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binding and Ca2+-release only induce relatively small
conformational changes most often confined to the
Ca2+-binding loop itself or to the close vicinity of the
EF-hand domain. Thus, the predominant function of
PV is assumed to lie in the control and/or modulation
of the spatio-temporal aspects of intracellular Ca2+
([Ca2+]i) signals (reviewed in [19–21]). These signals
are very short-lived, especially in excitable cells such
as neurons or muscle cells, in the range of few to
hundreds of milliseconds, and are termed Ca2+ tran-
sients. Depending on the cell type and the spatio-
temporal aspects, various names are given to these
Ca2+ transients; waves, spikes, sparks, puffs, quarks,
just to name a few; for details on the “taxonomy of
elementary cellular Ca2+ signaling events”, see [22]. In
the following chapters, I discuss how different Ca2+
buffersmodulate suchCa2+ transients and their effects
on cell physiology. Evidently even Ca2+ sensors are
able tomodulate Ca2+ transients, when present at high
enough concentrations. I focus mainly on recent
findings on the Ca2+ buffers PV (a and b lineage, the
latter also called oncomodulin, OM), CB-D9k, CB-
D28k and CR. Several extensive reviews on the
classical Ca2+ sensors including CaM [16, 17], the
S100 family [6] and the neuronal calcium sensor
(NCS) family [23, 24] have been published recently. I
also discuss the possible dual roles of CB-D28k and
CR, as buffers as well as sensors.
Relevant parameters to describe the properties of
Ca2+ buffers/sensors
In many initial studies, Ca2+ affinities, often repre-
sented by the dissociation constant KD,Ca, were amajor
focus of research on CaBPs as well as how changes in
the essential amino acids of the Ca2+-binding loop
affect the binding properties (for review, see [25, 26]).
Also, with the help of intracellular fluorescent Ca2+
indicators, it became clear that, under resting con-
ditions, [Ca2+]i is in the order of 50–100 nM in almost
all cells, including neurons and muscle cells. Based on
the reported CaBP dissociation constants (KD,Ca) that
are mostly in the low micromolar range, most of the
Ca2+-buffering protein molecules are evidently in the
Ca2+-free form under conditions of a resting (non-
activated) cell. Yet following a rise in [Ca2+]i due to
Ca2+ influx orCa2+ release from internal stores, CaBPs
will modulate the spatio-temporal aspects of Ca2+
signals. These Ca2+ transients in excitable cells are
often of short duration (in the range of 10 to several
100 ms) and highly localized, e.g., within the presy-
naptic terminal of axons or in sites flanking the Z-lines
and colocalized with T-tubules in muscle fibers [27].
The most important parameters relating to this
modulating function include: (a) the cytosolic con-
centration of the buffermolecules, (b) their affinity for
Ca2+ and possibly other metal ions (e.g., Mg2+), (c) the
kinetics of Ca2+ binding and release, and (d) their
mobility inside cells (for details, see [20]). For practical
reasons, the Ca2+-binding ratio of endogenous buffers,
i.e. , the ratio of buffer-bound Ca2+ changes over free
Ca2+ changes (kS ~ [Ca
2+ buffer] / KD,Ca), according to
the single compartment and linear approximation
model [28, 29], is often used as a measure to express
the buffering capacity of various cell types. In
particular, if the identity and property of the various
CaBPs within a cell type are not known precisely.
Motor neurons are characterized by very low buffer-
ing (kS<50 [30]), “typical” neurons have values in the
order of 60–200 [31], and Purkinje cells expressing
high levels of CB-D28k and PV are characterized by
very high kS values in the order of 900–2000 [32].
For none of the proteins discussed in this review have
all four parameters mentioned above been deter-
minedwith precision in vivo. In the following chapters,
I summarize the current knowledge about specific
Ca2+ buffers with respect to the above-explained
parameters and how this affects cell physiology as well
as pathologies where these proteins might be impli-
cated. New findings with respect to protein structure,
Ca2+-binding properties, localization, putative func-
tion and briefly, the involvement in pathologies are
discussed.
Table 1 (Continued)
Protein (mouse gene name)
[references]
Comments/ initial reported phenotype
CaMKII-PV [231] Ectopic expression of PVunder the control of the CaM-dependent kinase II promoter. The increase
in [Ca2+]i in CaMKII-PV motor neurons mediated by immunoglobulins from ALS patients is
decreased. Mutant SOD1 (mSOD1) transgenic mice, an animal model of familial ALS, bred with
CaMKII-PV mice show reduced motor neuron loss and have a delayed onset of the disease.
PV-EGFP [232] In this transgenic reporter strain, the enhanced green fluorescent protein (EGFP) is expressed under
the control of the Pvalb promoter and EGFP expression is observed in cells normally expressing PV
(“PV-ir“ neurons, fast-twitch muscles, renal epithelial cells in DCT1)
4
ht
tp
://
do
c.
re
ro
.c
h
Parvalbumins (a and b lineage)
Structural aspects
Although the X-ray structure of PV was already
published in 1973 [2], not all secrets have been
revealed. PV (mol. mass ~12 kDa) is a remarkable
exception in the family of EF-hand proteins in several
ways. It is one of the few proteins with three EF-hand
domains, albeit only two functional ones with respect
to metal binding. The most N-terminal AB site is
unable to bind Ca2+ ions due to strong deviations from
the consensus Ca2+-binding loop sequence, but none-
theless the AB domain is necessary for the stability of
PV [33]. Furthermore, the CD and EF domains also
have peculiar properties, such that they bindCa2+with
high affinity and Mg2+ with a moderate affinity in a
competitive manner (dissociation constants: KD,Ca 
[Ca2+]i, i.e. , ~5–100 nM and KD,Mg < [Mg
2+]i, i.e. , ~5–
500 mM), and are thus termed Ca2+/Mg2+ mixed sites
(for details, see [25]). Thus, in the cytoplasm of a
“resting” cell (e.g. , fast-twitch muscle fibers, neurons)
with reported intracellular Mg2+ concentrations of
0.5–1 mM [34, 35], the mixed Ca2+/Mg2+ sites of PV
are occupied largely by Mg2+ (80–90%), which needs
to dissociate before Ca2+ binding can occur. Due to
this mechanism, i.e. , the rate of Ca2+ binding being
determined by the rather slow Mg2+ off-rate, PV is
considered to be a “slow” buffer and the kinetics of
Ca2+ binding can be closely mimicked by the slow
synthetic buffer EGTA. As in most proteins with an
even number of EF-hand domains, the two connected
domains CD and EF in PValso form a pair consisting
of two helix-loop-helix regions linked by a short
stretch of five to ten amino acid residues. In both sites
the Ca2+ ion is coordinated by seven ligands, best
described as a pentagonal bipyramid with the Ca2+ ion
sitting in the center and the ligands at the corners of
this structure (Fig. 1) [36]. While the crystal structure
of PV was known early on [2], in the last few years,
more structures of PV in solution from different
species or b PV structures have been published [37].
They include NMR studies on C and N relaxation of
the Ca2+-loaded pike and rat PV [18], the apo (metal-
free form) of rat a PV [38] and b PV [39]. The results
from these studies can be briefly summarized as: (i)
the Ca2+-loaded EF-hand domains of rat a PVas well
as the linker region connecting theCDandEFdomain
are extremely rigid structures in comparison to those
in CaM or CB-D28k and also the N and C termini of
PV have a low intrinsic mobility [18]. (ii) The solution
structures of rat a PV in the apo- and Ca2+-loaded
forms are quite similar, structural differences are
mainly observed in the loop region, and thus Ca2+-
binding does not require major structural rearrange-
ments [38]. (iii) The same holds also true for the Ca2+/
Mg2+ mixed site (EF) in rat b PV (dissociation
constants: KD,Ca ~45 nM and KD,Mg ~250 mM), while
the CD site, which is a Ca2+-specific site (KD,Ca
~0.6 mM, for details, see [40] and below), undergoes
significant structural alterations when Ca2+ is re-
moved from b PV. This includes a rearrangement of
the two helices in the CD site as well as a reorganiza-
tion of the hydrophobic core and remodeling of the
interface between the non-functional AB and the CD-
EF domains [39]. Thus, a and b PV not only differ in
the Ca2+ binding affinity of their CD site, the global
rigidity of a PV makes this molecule a prime candi-
date as a Ca2+ buffer, while the Ca2+-induced con-
formational changes in b PV may hint towards addi-
tional functions, possibly also as a Ca2+ sensor (see
below).
Another essential parameter for Ca2+ buffers is their
intracellular mobility. The diffusion coefficient (D) of
PV in aqueous solution (~140 mm2/s [41, 42]) is clearly
larger than in the myoplasm of skinned frog muscle
fibers (~40 mm2/s [43]) and in dendrites of cerebellar
Purkinje neurons, the latter determined by two-
photon fluorescence recovery after photobleaching
(FRAP; 43 mm2/s [44]). In other cellular compart-
ments of the same Purkinje neurons (soma, nucleus,
axon), the diffusional mobility is further decreased to
approximately 11 mm2/s [45]. Yet in all preparations,
when themobility of PV is compared to themobility of
a dextran molecule of a similar size (approx. 10 kDa)
that is expected not to specifically interact with
intracellular constituents, the mobility of the two
molecules decrease in a similar way. Thus, differences
in PV mobility in various cell compartments can be
principally attributed to differences in cytoplasmic
viscosity or tortuosity; results from all experiments on
themobility of PVare consistent with themodel of PV
being amobilemolecule freely diffusing in the various
cellular compartments of PV-expressing cells.
Nomenclature of genes and proteins of the PV family
Certain confusion in the literature has arisen from the
fact that in different species, other genes with close
homology to a PV (human gene name PVALB) exist.
The encoded proteins consist of 107–113 amino acids
and have apparent molecular masses of 12 000–
14 000. According to the amino acid sequence, iso-
electric point and also Ca2+-binding characteristics,
PVs from different species have been classified into a
and b lineages (for details see [25]), and in different
species completely different names were given to
b PVs. In mammals b PV is known under the name
oncomodulin (human gene symbol OCM). The pro-
teins encodedby the two b PV forms in birds are either
called avian thymic hormone (ATH), thymus-specific
PV or thymus-specific antigen T1 (gene name:
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PVALB), while the other form is named oncomodulin
or PV 3 (CPV3; gene name: OCM). Unfortunately,
the chicken a PV has also PVALB as a gene symbol.
The rat b PV (oncomodulin;OM)was first detected in
hepatic solid tumors [46]. Based on the strong
sequence homology to CaM and its apparent selective
expression in tumor tissue, the protein was named
OM. OM expression was later observed in the
cytoplasm of cytotrophoblasts of the placenta and in
early embryos of rodents and other mammals [47].
The other b PV form in chicken was first detected as a
thymus-specific antigen T1 in the chicken [48] and was
later named avian thymic hormone (ATH) based on
its ability to stimulate differentiation of T cell pre-
cursors and to enhance the proliferative activity of
certain mitogens [49, 50]. However, the most prom-
inent expression of b PV (OM), initially called CBP-
15 in the guinea pig, is in the inner ear, specifically
restricted to outer hair cells (OHC; [51]). Interest-
ingly, a PV is expressed in both inner hair cells (IHC)
and OHC in the organ of Corti [52]. Also the
expression of a and b PV is regulated differently;
b PVexpression only occurs after efferent innervation
starting from postnatal day 2 (P2) to P4 and in organ
cultures isolated before efferent innervation of OHC,
b PV expression fails to develop. In contrast, a PV
expression in IHC and OHC appears to be independ-
ent of efferent innervation. A detailed study by
Hackney and co-workers [53] determined the con-
centrations of all known Ca2+-buffering proteins
(a PV, b PV, CB-D28k, CR) in IHC and OHC also
during development. The a PV concentration in IHC
and OHC from rat and mouse is around 100–300 mM
and tenfold higher concentrations of b PV (2–3 mM)
are found in OHC. A comprehensive review on Ca2+
signaling mechanisms in hair cells, in particular the
ribbon synapse has been published recently [54].
Ca2+/Mg2+ mixed sites vs Ca2+-specific sites
Many studies have attempted to elucidate the mech-
anism by which a Ca2+/Mg2+ mixed site (e.g., the CD
site in a PV) can be converted into a Ca2+-specific site
(e.g., the CD site in b PV). This involved the swapping
of the entire CD domain from one protein to the other
[55] or site-specific changes of amino acid residues in
the CD loop of rat PVwith the ones present in rat OM
[56]. The results from these studies indicate that the
specificity (Ca2+/Mg2+ mixed vs Ca2+ specific) resides
within the whole CD domain, not only in the Ca2+-
binding loop. Finally, it was attempted to convert the
non-functional AB domain Ca2+-binding loop of PV
and OM into a functional one by replacing the 10-
residue-long nonfunctional loop in the AB by a
canonical 12-amino acid loop [33]. Yet, the introduced
mutations did not “reactivate” the AB domain, but
instead increased the cooperativity between the two
functional CD and EF domains (nH = 2). Thus, the
main function of the AB domain is likely to provide
conformational stability of metal-free PV.
Functional aspects of PV and OM
The delayed Ca2+-binding properties of PV together
with its large concentration (up to 3 mM) in fish
muscle led to the early hypothesis that PVmight act as
a relaxation factor by facilitating Ca2+ transport from
the myofibrils to the sarcoplasmic reticulum [57, 58]
(for a review on the role of PV in muscle, see [59]). A
direct role for PV in muscle relaxation was shown by
injecting PV cDNA into the slow-twitchmuscle soleus
(SOL) of a rat, where the speed of relaxation is
significantly increased, while contraction times are not
affected [60]. The opposite is seen in PV KO mice
(PV-/-, systematic name Pvalbtm1Swal ; Table 1): half-
relaxation rates of an electrically induced single twitch
in fast-twitch muscles, tibialis anterior (TA) are slower
in the absence of PV [61]. That is, PV is too slow to
affect the rapid rise in [Ca2+]i occurring during the
contraction phase, but increases the initial rate of
[Ca2+]i decay. Yet, under prolonged tetanic contrac-
tion, PV saturates with Ca2+ and acts as a transient
Ca2+ source, prolonging the [Ca2+]i decay and also the
relaxation phase [62]. The effects of PV on [Ca2+]i
decay performed in PV-injected chromaffin were used
to determine both the KD and the kinetic parameters
of Ca2+- and Mg2+-binding with high accuracy [63]
(Table 2). PV considerably increases the initial rate of
[Ca2+]i decay (Ca
2+-binding phase), followed by a
prolongation of the transient at later times (Ca2+-
releasing phase) yielding a bi-exponential [Ca2+]i
decay. Such a bi-exponential decay is seen in cultured
PV-containing hippocampal interneurons in vitro, but
not in excitatory neurons devoid of PV expression
[31]. This “signature” of PV is also seen in PV-
expressing neurons in slice cultures, both pre- and
post-synaptically. The results obtained from PV-/- as
well as otherCaBP-deficientmice have been reviewed
previously [21, 64] and are briefly summarized here.
At the synapses between stellate/basket cells and
Purkinje cells paired-pulse depression (PPR ~0.85) in
wild-type (WT) mice changes to facilitation (PPR
~1.17) at 30 ms interspike interval (ISI) in PV-/- mice
[65], due to the higher residual [Ca2+]i in the presy-
naptic terminals, i.e. , interneuron varicosities [66].
The effect of PV is most pronounced after short ISI
(30 ms) when [Ca2+]i decay curves in the presence or
absence of PV show the largest differences. Not only
the increase in initial [Ca2+]i decay is of importance,
but also the slow decay component, i.e. , PV, acting as a
Ca2+ source, leads to a robust PV-dependent, delayed
transmitter release at interneuron-interneuron synap-
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ses subsequent to presynaptic bursts of action poten-
tials [66]. Despite the fact that hippocampal PV-
expressing interneurons, axo-axonic and basket cells
[67] are likely involved in similar mechanisms as
cerebellar interneurons, no differences in paired-pulse
modulation between control and PV-/- mice are
apparent; the expected “PVeffect” is only seen
when pulse trains at 33, 50 and 100 Hz are delivered
indicative ofmore efficient presynaptic Ca2+ extrusion
mechanisms in hippocampal PV interneurons [68].
Evidently, the “steady-state” [Ca2+]i level during a
series of burst-like action potentials (AP) depends
uponDt/t ;Dt being the time interval betweenAPs and
t the Ca2+ relaxation time constant of individual Ca2+
transients. At stimulation frequencies of 20 Hz or less
(ISI>50 ms), both in the presence and absence of PV,
the decay in [Ca2+]i is fast enough to prevent buildup
of residual Ca2+ and becomes manifest only at higher
frequencies (>30 Hz). Interestingly, the relative effect
of PV in preventing facilitation is strongest at ~33 Hz,
within the range of gamma frequency (30–80 Hz)
oscillations. The maximum power of gamma oscilla-
tions in vitro recorded with dual field potential
recordings in area CA3 from PV-/- mice is higher
than in control mice and can be explained by an
increased facilitation of GABA release at sustained
high frequencies. The physiological consequences of
this effect at the network level are discussed below.
Although principally expressed in GABAergic inter-
neurons, PV is also present at a large excitatory nerve
terminal in the auditory brainstem, the calyx of Held,
where presynaptic Ca2+ plays a crucial role in short-
term plasticity. This synapse is characterized by a very
fast Ca2+ decay (tfast ~30 ms) that slows down during
presynaptic whole-cell recordings as the result of
washing out of (an) endogenous mobile Ca2+ buffer(s)
(e.g., PV). The loss of these buffers only marginally
increases the amplitude of the [Ca2+]i transient,
indicative of a “slow” buffer being responsible for
the effect. Addition of PV in the recording pipette
restores both the fast decay kinetics of [Ca2+]i and
paired-pulse facilitation [69]. Results from the “run-
down” whole-cell recordings in rat neurons are very
similar to recordings made in PV-/- neurons after brief
preloading with the Ca2+ indicator fura-6F, further
supporting the role of PV in accelerating the decay of
spatially averaged [Ca2+]i and paired-pulse facilita-
tion. The role of postsynaptic PV was addressed in
PV-/- Purkinje cells by analysis of the climbing fiber-
mediated Ca2+ transients in spiny dendrites [70]. As in
other neurons, the Ca2+ peak amplitude is not
significantly altered, while the biphasic nature of the
[Ca2+]i decay – the typical signature of the slow
binding kinetics of PV – is greatly reduced in the
absence of PV. What are the global consequences of
eliminating PV from this network of inhibitory
neurons often critically involved in strong perisomatic
inhibition? Previously, it was hypothesized that a
change in the inhibitory activity of PV neurons in the
neocortex may be a major mechanism underlying
epileptic seizures [71]. Although PV-/- mice show no
signs of spontaneous epileptic activity, pentylenete-
trazole (PTZ)-induced seizures, albeit delayed, are
more severe in PV-/- than in WT mice [72]. This
indicates that the inhibitory effect exerted by the
subpopulation of “PV interneurons” of the cerebel-
lumandhippocampus is enhanced in the brain of PV-/-
mice. In the hippocampus, the absence of PV facili-
tates the GABAAergic current reversal induced by
high-frequency stimulation and thereby the procon-
vulsive GABA-mediated depolarizing postsynaptic
potential. In summary, PV plays a major role in
regulating the local inhibitory effects exerted by
GABAergic interneurons on principal neurons.
PV deficiency also affects cerebellar function(s),
likely involving the entire circuit. As in CR-/- and
CB-D28k-/- mice [73], the absence of PV induces 160-
Hz oscillations sustained by synchronous, rhythmic-
firing Purkinje cells aligned along the parallel fiber
axis. Cell firing alterations include a decrease in
complex spike duration and spike pause, and an
increase in simple spike firing rate (for details, see
[74]). At the behavioral level, these changes are likely
responsible for the very mild locomotor phenotype,
i.e. , an impairment of motor coordination/motor
learning [75]. Note that all the reported changes are
also seen in CB-D28k-/- mice and the highest magni-
tude of most changes observed at the cellular level are
also manifested as a greater impairment in motor
coordination/learning in CB-D28k-/- mice [75, 76].
PV and neurological diseases?
Many studies have reported alterations in the expres-
sion of CaBPs including PV in various brain regions of
postmortem patients with specific pathologies includ-
ing Alzheimers, Huntingtons and Parkinsons dis-
ease, various types of ataxia, and disorders such as
epilepsy, schizophrenia, bipolar disorder and depres-
sion (for a review, see [64, 77, 78]). Also changes in PV
expression have been reported in animal models of
these diseases. Yet in many cases, authors report
correlations such as “down-regulation of PV in the
area XY of Z patients”, but most often it is not
investigated whether (a) PV expression is reduced in
this neuron subpopulation, (b) this subpopulation of
neurons have degenerated, or, moreover, (c) whether
PV is involved in the observed changes.Within the last
few yearsmany reports of this type have appeared, but
unfortunately little knowledge on the function of
CaBPs can be gleaned from these studies.
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Role of PV in kidney function
Besides muscle and brain, PV is also expressed in the
kidney. In the rat, PV expression occurs in part of the
distal convoluted tubule and proximal collecting duct
[79]. More recent studies in the mouse revealed that
PV is essentially localized to the early distal con-
voluted tubule (DCT1) that plays an essential role in
NaCl reabsorption, where it colocalizes with the
thiazide-sensitive Na+/Cl- cotransporter (NCC; for a
general review on transcellular Ca2+ and Na+ trans-
port pathways in the murine distal nephron, see [80]).
A significant overlap exists between PV expression
and the Mg2+ channel involved in renal Mg2+ absorp-
tion, TRPM6 [81]. Increased diuresis and kaliuresis at
baseline together with higher aldosterone levels and
lower lithium clearance are seen in PV-/- mice [82].
Unexpectedly, acute furosemide administration does
not increase calciuria; calciuria is increased only after
NaCl supplementation, both at baseline and after
furosemide treatment. In PV-/- kidney, expression of
NCC is down-regulated. Overexpression of PV in
mouse DCT cells in vitro induces endogenous NCC
expression, suggesting that PV could act as a Ca2+-
dependent modulator of NCC expression levels. The
finding that PV-/- mice have a positive Ca2+ balance
and increased bone mineral density were interpreted
to be related to NCC down-regulation, as a similar
phenotype is seen in patients and mice having NCC
deficiency, but could hint also that homeostatic
mechanisms involving up-regulation of CB-D9k take
place when PV is missing (for additional details, see
also Transgenic mice used to study the “Ca2+ homeo-
stasome” in renal and intestinal Ca2+ regulation
below).
Regulation of PVs
Different factors regulate PV expression in both
muscle and neurons. PV is regulated by estrogen via
estrogen-receptor (ER) b. Expression of PV is in-
creased in males and decreased in female ERb-/-
Table 2. Properties of selected Ca2+-binding proteins in comparison to the synthetic buffers EGTA and BAPTA (adapted from [64]).
EGTA BAPTA a PV b PV (OM) CB-D9k CB-D28k CR
Ca2+ binding sites (functional) 1 (1) 1 (1) 3 (2) 3 (2) 2 (2) 6 (4) 6 (5)
Ca2+-specific /mixed Ca2+/Mg2+ sites 1/0 1/0 0/2 1/1 2/0 4/0a 5/0
KD,Ca (nM)
KD,Mg
KD,Ca(app) (nM) at [Mg
2+] of 0.5–1 mM
70–150 160 4–9b
~30 mMb
150–250c
Mixed: 42–45d
Ca2+-specific:
590–780d
160–250 mMd
230–310 nMc
KD1 ~200–500
e
KD2 ~60–300
High aff. (h)f
KD1 ~180–240
medium aff. (m)
KD2 ~410–510
714 mMa
KD(T) 28 mM
g
KD(R) 68
KD(app) 1.4 mM
EF5: 36 mM
4.5 mMh
kon,Ca (mM
-1 s-1)
kon,Mg (mM
-1 s-1)
3–10f,i 100–1000f,i 6b
0.1–1c
up to 1000e h sites ~12f
m sites ~82
2 T sites: 1.8 g
2 R sites: 310
site EF5: 7.3
koff,Ca (s
-1) = KD,Ca * kon
koff,Mg (s
-1)
0.5–1.5 16–160 0.9–1.03j
3.42j
11–25j
h sites: 2–3f
m sites: 34–42
T sites ~50 g
R sites ~20
site EF5 ~260
Cooperativity nok ? yesl yesm yes
nH ~1.1–1.2
a
yes
nH ~1.3–1.9
g
DCabuffer (mm
2 s-1) 200 n 200 n 37–43o
~11
>100p
~25
~25p
a Based on the affinity for Mg2+ [126], the sites may also be considered as mixed sites, but the Ca2+/Mg2+ antagonism is much less
pronounced than in the two and onemixed sites ofa and bPV, respectively. b [233]. cKDand kon for PVare highly dependent on [Mg2+] –
the values stated are estimates at physiological cytosolic [Mg2+] (0.6–0.9 mM). d [40]. e The reported value represents the diffusion limit,
assuming a maximal Ca2+ diffusion rate of ~200 mm2 s–1 [104, 234]. f The four functional sites of CB can be classified as either medium-
affinity (m) sites with fast binding kinetics or high-affinity (h) sites with slower binding kinetics [125]. Themodel gave equally good results
with CB-D28k having two high and two medium sites or three high and one medium site. Cooperativity of Ca2+-binding sites was not
included in the model to calculate the different parameters. g For details, see Fig. 3 and text [174]. h [171]. i [235]. j [57, 63, 236]. k PV has
two essentially identical Ca2+-binding sites with nH close to 1. l [90]. m [237]. n Values for EGTA and BAPTA are based on the reported
mobility (283 mm2 s–1) of IP3 [238]. o The diffusion coefficients DCabuffer for PVare very similar in muscle myoplasm (37 mm2 s–1) [43]
and in dendrites of Purkinje cells (43 mm2 s–1) [44], but are smaller in the somaand axons (~12 mm2 s–1) [45]. pWhile themobility is rather
high inwater [239], mobility of CB-D28k inside Purkinje cell dendrites is only 26 mm2 s–1 [128], clearly slower thanPV.Themobility of CR
is assumed to be similar as for CB-D28k based on the similar molecular mass of CB-D28k and CR.
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muscles [83]. Interestingly, ERb is strongly colocal-
ized with PV-immunoreactive neurons in many brain
regions (cortex, amygdala, basal forebrain and hippo-
campus) [84]. Two other factors implicated in the
regulation of PVexpression are electrical activity and
light. Both chronic low-frequency stimulation of fast-
twitch muscles [85] or denervation [86] lead to a
significant decrease in PV expression, indicating that
PV expression is under the control of fast-type motor
neuron activity. Circadian variation of PV expression
is observed in AII amacrine neurons of the rat retina
[87] and also in the ciliated ependymal layer of the
third ventricle at the level of the suprachiasmatic
nuclei (SCN) [88]. Light exposure during late sub-
jective night decreases PV staining in the cilia. Also in
hair cells, expression of PVandOM is likely regulated
during cochlear development and may be influenced
by efferent innervation [52].
OM, initially detected in rat kidney tumors and
derived cell lines, is present in the organ of Corti, the
auditory receptor organ [51] and in gerbil, rat and
mouse OM is exclusively expressed in cochlear OHCs
[89]. A recent report showed that OM might act as a
potent macrophage-derived growth factor for retinal
ganglion cell (RGC) regeneration [90], indicating also
a Ca2+ sensor role. OM binds to rat RGCs with high
affinity in a cyclic AMP (cAMP)-dependent manner
and stimulates more extensive axon outgrowth than
other known trophic agents. An OM-dependent
activation of cAMP phosphodiesterase (increased
cAMP hydrolysis) has been reported [91]. Thus, it
was suggested that OM is a new growth factor for
neurons of the mature central and peripheral nervous
systems. The latter finding was challenged recently,
since (a) OM was reported to be not significantly
expressed in primary macrophages, (b) intraocular
OM levels did not increase after lens injury or
zymosan treatment, and (c) strongly reducing macro-
phage invasion into the inner eye increased, not
decreased axon regeneration into the optic nerve [92].
Thus, the role of OM as a putative neurotrophic factor
is a novel exciting topic, but it is certainly too early to
make any conclusive statements. An action as a
hormone, i.e. , to promote immunological maturity in
chicken bone marrow cells in culture, was also
reported for the second b lineage type PV, called
avian thymic hormone (ATH) [93]. ATH has also two
Ca2+/Mg2+ mixed sites similar to the “muscle and
neuron”-type PV [94] and unlike OM that contains a
Ca2+-specific and a mixed Ca2+/Mg2+ site. Since the
ATH amino acid sequence is very similar to reptile
(turtle, salamander and frog) b-type PVs, the authors
proposed, “the evolutionary appearance of the warm-
blooded reptiles was accompanied by recruitment of
the b PV isozyme for promotion of lymphocyte
maturation” [95]. The chick ortholog of OM, CPV3,
is also expressed in thymus tissue. Further evidence
that CPV3 is an OM isoform was provided by flow-
dialysis measurements indicating that the Ca2+-bind-
ing domains are not equivalent [96]. Both CPV3 and
ATH are produced by epithelial cells in the thymic
cortex of chickens. ATH circulates in the blood on a 5-
day cycle and stimulates the development of cell-
mediated immunity, further evidenced by an en-
hanced acute graft-versus-host reaction [97].
Calbindin-D9k
Structural and general aspects of CB-D9k
Since its discovery in 1967 [4], CB-D9k has served as a
most useful model EF-hand protein. It is the smallest
one with an EF-hand pair consisting of a “canonical”
EF-hand domainwith aCa2+-binding loop of 12 amino
acids (EF2) and a non-canonical (also termed “pseudo
EF-hand”) Ca2+-binding loop comprising 14 amino
acids (EF1), typical for the S100 family proteins [6]. In
contrast to the canonical loop, where Ca2+ binding
occurs mainly via carboxyl side chain groups (Fig. 1),
most of the ligands chelating the Ca2+ ion in the non-
canonical loop of the S100 family proteins are back-
bone carbonyl groups [98]. Structural data obtained
by X-ray, NMR [99, 100] and electrospray ionization
mass spectrometry [101] methods together with the
production of mutants with specific amino acid sub-
stitutions have revealed the most important structural
features. The four a-helical regions are organized in
two EF-hand domains joined by a linker region of ten
amino acids and between the twoCa2+-binding loops a
short b-type interaction exists [102]. When artificially
cleaving the protein into two halves, the Ca2+-binding
rates of the individual subdomains are several orders
of magnitude lower than for the corresponding sites in
the intact protein, indicating that EF-hands organized
in tandem domains are the functionally relevant
structures ([103], for a review, see [98]). The two EF-
hand domains bind Ca2+ with similar affinities and
positive cooperativity [104], also in the presence of
physiological Mg2+ concentrations [105]. The overall
Ca2+-induced conformational change in CB-D9k is
much less pronounced than in the typical sensor CaM,
an argument in favor of CB-D9kmainly serving a role
as a Ca2+ buffer compared to functioning as a Ca2+
sensor [106]. In rat kidney, CB-D9k is expressed in the
loops ofHenle and the distal convoluted tubule. In the
collecting duct CB-D9k is restricted to the interca-
lated cells [107]. In the immunoreactive cells, labeling
was found to be strongest along the basolateral
membrane, but until now, no evidence for CB-D9k
either interacting with membrane constituents or with
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any other molecule has been presented. Thus, the
“selective” staining of CB-D9k along the basolateral
membrane might be an artifact for various reasons,
i.e. , better fixation of the small CB-D9k molecule in
the dense network of proteins on the inner surface of
the basolateral membrane. Also binding of antibodies
to their target CaBP is typically sensitive to the metal-
binding status [108, 109] and may not be identical
throughout the cell. Unlike for PV (for details see
above), the mobility of CB-D9k in the various cells
expressing this protein has not been reported so far,
but based on the absence of identified binding
partners and rather minor Ca2+-dependent conforma-
tional changes, CB-D9k is assumed to be a freely
mobile molecule, the mobility likely determined by
the viscosity and/or tortuosity of the cytoplasmic
compartment. An analysis of the mouse kidney
revealed CB-D9k to be strongly expressed in distal
convoluted tubules [110], more precisely in the late
distal convoluted tubules and the connecting tubules
(J. Loffing, personal communication) and thus highly
colocalized in the same structures previously reported
to express the epithelial Ca2+ channel TRPV5 (Fig. 3
in [80]). In the mouse intestine, strong expression of
CB-D9k is restricted to the first 2 cm of the duodenum
[111].
Functional aspects of CB-D9k
The regulation of CB-D9k expression by 1,25(OH)2
vitamin D3 (D3) led to the initial discovery of this
protein in intestine [4], but other ways of regulation
were identified in other tissues (for a comprehensive
review on CB-D9k, see [112]). A functional estrogen-
responsive-like element located at position +51 from
the transcriptional initiation site in the rat gene
sequence (S100G) is responsible for the estrogen-
mediated expression of CB-D9k in the uterus [113]. A
screen for estrogen-responsive genes in the rat pitui-
tary cell line GH3 revealed the CB-D9k mRNA to be
up-regulated almost 100-fold after 17-b-estradiol (E2)
treatment [114]. Interestingly, the other strongly up-
regulatedmRNAwas the one corresponding to thePV
(PVALB) gene. Uterine CB-D9k mRNA levels are
also increased in rats treated with xenobiotic agents
acting as endocrine disruptors [115] via an ER-
dependent pathway. Most recently, a non-classical
pathway involving NF-kB was shown to contribute to
elevated CB-D9kmRNA levels in GH3 cells [116] via
an NF-kB-responsive element -848 to -834 from the
transcriptional start site in the rat CB-D9k promoter.
In mouse primary renal tubular cells, CB-D9kmRNA
is also positively modulated by parathyroid hormone
(PTH), acting synergistically with D3 [117]. Besides,
endocrine regulation, intestinal CB-D9k is also regu-
lated by Mg2+; in rats fed a low Mg2+ diet, CB-D9k
concentration increases, while at high Mg2+, CB-D9k
remains unchanged [118]. Renal CB-D28k levels are
not affected by the low Mg2+ diet, but are lower in
animals fed a highMg2+ diet, indicating that CB-D28k
is also regulated by Mg2+.
In the kidney, immunoreactivity against PV and CB-
D9k is detected in the rat distal convoluted tubule and
the latter also in the connecting tubule. The strongest
staining localized to the basolateral membranes was
used as an argument proposing a role in the regulation
of Ca2+ transport processes rather than a role as a Ca2+
buffer and/orCa2+ shuttle [107, 119]. This is in contrast
to the theoretical work describing CB-D9k as a Ca2+
buffer/shuttle optimally tuned for transcellular Ca2+
transport [120]. Increased transcellular Ca2+ transport
in a colon cancer cell line (Caco-2) is observed in vitro
after D3 administration, which leads to an increase in
CB-D9k levels hypothesized to cause facilitation of
transcellular Ca2+ transport [121].
Calbindin-D28k
Structural and general aspects of CB-D28k
CB-D28k has sixEF-hand domains, four ofwhich bind
Ca2+ with medium/high affinity in the intact protein
[122]. In all studies EF-hand 2 is considered non-
functional, whileEF-hand 6may bindCa2+, albeit with
very low affinity. This, however, was determined not in
the intact protein, but using a peptide comprising the
sequence of EF-hand domain 6 [123, 124]. In classical
terms, the four medium/high affinity sites, sites 1, 3, 4
and 5 (KD,Ca ~500 and 200 nM, respectively, for details,
see below; [125]) are considered to be Ca2+-specific
sites, although Mg2+ binding to the same sites with
much lower affinity (KD,Mg ~700 mM)would also allow
the classification as Ca2+/ Mg2+ mixed sites. Thus, in
the presence of physiological Mg2+ concentration
(0.5–1 mM [34, 35]), the apparent Ca2+ affinity is
decreased by approximately a factor of 2 and, more-
over, cooperativity of Ca2+ binding in CB-D28k
increases [126]. Compared to PV, the on-rate of Ca2+
binding of CB-D28k under physiological conditions
inside a cell (kon ~1.110
7–8107 M-1 s-1) is almost one
order of magnitude faster (PV: 3106–6106 M-1 s-1
[20]), in particular it is the faster sites that have lower
affinities [125]. Thus, in activated neurons, already the
early phase of Ca2+ transients are affected by CB-
D28k, blunting the peak amplitude of Ca2+ transients
as has been shown in Purkinje cells of CB-D28k-/-
mice [127]. Nonetheless, the time to peak is not
significantly affected in the absence of CB-D28k,
indicating that the initial [Ca2+]i rise is essentially
governed by the properties of theCa2+ channels, albeit
Ca2+ binding to CBs fast, medium-affinity sites inWT
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Purkinje cells already occurs during the early rising
phase as modeled before (Fig. 7D in [70]).
Mobility of CB-D28k and CB-D28k interaction
partners
The mobility of CB-D28k inside cells, i.e. , in spiny
dendrites of cerebellar Purkinje cells, was addressed
by FRAP experiments. While the majority of CB-
D28k molecules move with a diffusion coefficient of
20 mm2/s [128], approximately twofold slower than PV
measured in the identical cellular compartments and,
according to themodel expectations, in comparison to
dextrans of similar molecular weight, an immobile
fraction is observed in spines and dendrites, but not in
axons of Purkinje cells. The immobilization involving
approximately 20% of CB-D28k molecules in spines
and dendrites lasts for several seconds and can be
increased by climbing fiber stimulation at either 1 or
20 Hz, in the latter case immobilization is even more
enhanced (~70% higher than in unstimulated cells;
[128]). The interacting binding partner in Purkinje cell
spines and dendrites is myo-inositol monophospha-
tase (IMPase), a key enzyme of the inositol-1,4,5-
triphosphate signaling cascade. In vitro CB-D28k
associates with IMPase [129] as well as with Ran-
binding protein (RanBP) M [130] as evidenced by
NMR methods. Additional reported CB-D28k bind-
ing partners include caspase-3 [131], 3,5-cyclic nu-
cleotide phosphodiesterase [132] and plasma mem-
brane ATPase [133]. Recently, the L-type Ca2+
channel subunit CANAC1C [134] was identified as a
binding partner of CB-D28k, and in the kidney CB-
D28k binds to TRPV5 andmodulates its activity [135]
(see Transgenic mice used to study the “Ca2+ homeo-
stasome” in renal and intestinal Ca2+ regulation
below). The binding peptide SKSIKNLEP of procas-
pase-3 is highly similar to the reported IMPase peptide
(see below), suggesting that both bind to the same
epitope on CB-D28k [136]. These studies together
with those on Ca2+-dependent conformational
changes indicate that CB-D28k also has character-
istics of a Ca2+ sensor [126], although the Ca2+
dependency of the interaction between CB-D28k
and binding partners has not been directly demon-
strated yet. The binding sites in CB-D28k interacting
with RanBP M have been mapped by NMR and
include the N terminus and two regions that exhibit
conformational exchange on the NMR timescale
(Fig. 2) [130]. NMR interactions with the IMPase
peptide SYSSIAKYPSHS yielded essentially identi-
cal results, indicating that both IMPase and RanBPM
bind to CB-D28k in a similar fashion. In further
support of CB-D28k acting as a Ca2+-sensor is the
finding that retroviral-mediated overexpression of
CB-D28k in hippocampal progenitor cells increases
neuronal differentiation and also neurite outgrowth
[137]. The same study showed that increased CB-
D28k also increases expression of basic helix-loop-
helix transcription factors and the phosphorylation of
CaM-dependent protein kinase II (CaMKII) and of
NeuroD in both fetal and adult hippocampal progen-
itor cells. Whether the effect is truly specific for CB-
D28k or a general Ca2+-buffering effect was not
addressed.
NMR structure of CB-D28k
Structural data on CB-D28k have appeared only very
recently, despite several labs including the authors
own attempting to obtain crystals for the six EF-hand
proteins CB-D28k and CR. In 2006, the solution
structure of Ca2+ -bound rat CB-D28k, the largest
structure solved then, was elucidated by NMR [136].
The protein depicted in Figure 2 is made of a single,
almost globular (ellipsoid) fold consisting of six
distinct EF-hand domains. As explained above, the
peptide regions of RanBP M, procaspase-3 and
IMPase interact with a surface of CB-D28k consisting
primarily of the N-terminal part, the first helix of EF-
hand domain 3, the second helix of domain 4 and
residues in the linker regions EF2-EF3 and EF4-EF5
of CB [136]. Interestingly, when comparing the
residues proposed to either directly bind the target
peptides (Ala2–Asn7; [130]) or to undergo significant
conformational changes [136], the residues show low
homology to the closely related CR (Fig. 2), suggest-
ing that CR would likely not bind to the CB-D28k
targets, a hypothesis that could be tested experimen-
tally. A brief report on the crystal structure of human
CB-D28k has appeared, but no details have been
given so far [138].
Functional aspects of CB-D28k
Since its discovery in the 60 s,many roles for CB-D28k
have been proposed and include a role in Ca2+
resorption in the kidney, modulation of insulin
production and secretion in pancreatic b cells [139,
140] and neuroprotection against excitotoxicity. Re-
sults on a neuroprotective role are rather inconsistent
(e.g., [141–146]; some earlier work is summarized in
[64, 77]). The role ofCB-D28k in renalCa2+ resorption
is addressed below. In 1997, the production of CB-
D28k-null mutant mice (systematic name:
Calb1tm1Mpin ; Table 1) was reported; CB-D28k-/-
mice manifest no overt phenotype that is related to
(a) development, (b) the general morphology of the
nervous system or (c) behavior under standard hous-
ing conditions [127]. However, the mice show a mild
impairment inmotor coordination/motor learning [75,
127] that is likely the result of the observed 160-Hz
oscillations in the cerebellum [73, 76] (see also section
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on Calretinin below). The importance of CB-D28k in
cerebellar Purkinje cells and cerebellar function is
seen in a mouse strain, where the protein is selectively
eliminated in Purkinje cells [147]. Both, the motor
coordination phenotype and the alterations in Pur-
kinje cell physiology are almost identical to the ones
seen in the “global” KO (CB-D28k-/-) mouse strain
[148]. It consists of changes in synaptically evoked
postsynaptic Ca2+ transients, i.e. , the amplitude is
increased and the fast, but not the slow, [Ca2+]i decay
component has a larger amplitude in CB-D28k-/- than
inWTmice [127]. The contribution of CB-D28k in the
modulation of Ca2+ signals in Purkinje cell dendrites
and spines was further determined by comparing Ca2+
transients in PV-/- cells with those from PV-/-CB-
D28k-/- ones, assuming that the differences in theCa2+
signals are brought about by the absence of CB-D28k
[70]. In the first ~100 ms, CB-D28k acts as a Ca2+
buffer reducing the peak [Ca2+]i amplitude to about
one half, while from this time on the protein acts as a
Ca2+ source, slowing the later phase of the [Ca2+]i
decay. Not only the slow buffer PV contributes to the
biphasic [Ca2+]i decay kinetics, but also the high-
affinity Ca2+-binding sites of CB-D28k characterized
by rather slow kinetics [125] contribute to the biphasic
decay. Despite the marked differences in the shape of
Ca2+ transients, the absence of CB-D28k in Purkinje
cells has no effect on the long-term depression (LTD)
of Purkinje cell-parallel fiber synaptic transmission
[148], suggestive of putative compensation mecha-
nisms. On the other hand elimination of type 1 inositol
1,4,5-triphosphate receptor implicated in the same
metabotropic glutamate receptor/IP3/Ca
2+ signaling
pathway is accompanied with both severe ataxia and
impaired LTD [149].
Modulation of synaptic plasticity by CB-D28k
The absence of CB-D28k also affects short-term
plasticity evidenced either in cortical multipolar
bursting cells (MBC) or at the mossy fiber-CA3
pyramidal cell synapse in the hippocampus [150].
The saturation of mobile, fast, high-affinity cytosolic
Ca2+ buffers transiently decrease the presynaptic
Ca2+-buffering capacity leading to enhanced facilita-
tion [29, 151] and this mechanism is termed “facili-
tation by buffer saturation”. Thus, the elimination of a
fast buffer either in CB-D28k-/- neurons or as a
consequence of the washout of cytosolic constituents
in WT cells via the patch pipette increases the
amplitude of the first response and subsequently
decreases the paired-pulse ratio. The effect of CB-
D28k in this process is to cause a decrease in
presynaptic [Ca2+]i and hence the inhibitory post-
synaptic-potential during the first response in the
paired-pulse protocol. This effect is observed after
adding the fast synthetic buffer BAPTA or CB-D28k
to theMBC-attached pipette [150]. Themodulation of
synaptic transmission by the addition of exogenous
Figure 2. The three-dimensional structure of CB-D28k based on
NMR measurements [136]. (A) The protein (shown is the back-
bone) has a relatively compact structure and consists of four
functional (1, 3, 4 and 5) and two non-functional (2, 6) EF-hand
domains. The Ca2+-binding loops flanked by the two a-helical
regions are numbered from 1 to 6. From the N-terminal (NH2)
region (dark blue, EF1) the protein extends to the C terminus
(COOH) and changes the color along its way from light blue (EF2),
bluish-green (EF3), green (EF4), yellow-orange (EF5) and orange-
red (EF6). Side chains are shown for amino acids strongly changing
the NMR signal after binding to the interacting peptide IMPase or
RanBPM(for details, see text). Themost strongly affected residues
lie within themostN-terminal region, but the binding interface also
includes Val90, the first helix of EF-hand domain 3, the second helix
of domain 4 and residues in the linker regions EF2-EF3 and EF4-
EF5 of CB-D28k (side chains not shown) [136]. The binding region
extends from the N terminus up to approximately the center of the
image. The imagewas generated using PDBProteinWorkshop 1.50
[228] using the structure of calbindin (CB)-D28k (PDBcoordinates
2G9B). (B) Sequence comparison of the peptides derived from
myo-inositol monophosphatase (IMPase) (upper) and procaspas-
es-3 (lower) binding to CB-D28k. (C) Amino acids of CB-D28k
(lower sequence), whose NMR signals most strongly change after
peptide binding (yellow) are generally poorly conserved between
human CB-D28k and calretinin (CR) (upper sequence), indicating
specificity of ligand binding. The amino acids comprising the
functional Ca2+-binding loops, 1–5 in CR and 1, 3, 4 and 5 in CB-
D28k, are marked red, the non-functional ones blue.
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buffers such as BAPTAhas been described before and
was termed pseudofacilitation [152, 153].
A rather similar process also exists in other neurons
and was initially observed in tissue obtained from
postmortem brains of patients with Ammons horn
sclerosis [154], in an animal model of mesial temporal
lobe epilepsy, and in CB-D28k-/- mice [155]. In all
three cases, CB-D28k is absent from granule cells of
the dentate gyrus. This significantly increases the
Ca2+-dependent inactivation of voltage-dependent
Ca2+ currents (ICa) and diminishes Ca
2+ influx during
repetitive neuronal firing, an effect that is lost on
addingBAPTAorCB-D28k to the pipette.Hence, the
loss or down-regulation of CB-D28kmay be viewed as
a protective or homeostatic mechanism to limit Ca2+
influx to increase the resistance against excitotoxicity
and to protect the surviving neurons.
The two parameters of a Ca2+ buffer, i.e. , the Ca2+-
binding kinetics together with the mobility define the
range of action of a Ca2+ ion in the presence of one or
several CaBPs, affecting excitability, and also plasti-
city, not only short-term, but also long-term plasticity.
In a model study, the spino-dendritic coupling in
Purkinje cells and the role for dendritic Ca2+ homeo-
stasis and downstream signaling cascades was inves-
tigated using data obtained in PV-/- and CB-D28k-/-
PV-/- mice [156]. CB-D28k is the more important
“Ca2+ transporter” than PV that, by buffered diffu-
sion, also transiently increases [Ca2+]i in dendritic
shafts. These [Ca2+]i elevations appear sufficient to
activate CaM and thus, CaM-dependent processes,
representing a novel form of signal integration
mediated by the properties of CB-D28k.
Role of CB-D28k in the auditory and visual system
CB-D28k is expressed in specific neurons in the visual
and auditory systems, thus the putative role of CB-
D28k was studied in CB-D28k-/- mice. CB-D28k is
expressed in hair cells of the inner ear, most prom-
inently in the OHC, where concentrations of 160–
230 mMwere measured in rat neurons [53] and within
distinct neurons of the auditory pathway. Surprisingly,
no differences either in the auditory brainstem-
evoked response, in the distortion-product otoacous-
tic emissions or in noise-induced trauma that results in
hair cell loss were observed when comparingWTwith
CB-D28k-/- mice [157]. At that time it was not yet
known that hair cells also express significant amounts
of CR and PV (a PV in both OHC and IHC), b PV
most strongly in OHC [53]). Thus, it may well be that
the remaining CaBPs compensate for the loss of CB-
D28k and these results do not necessarily argue
against an essential role forCB-D28k either in hearing
or in protecting against moderate noise-induced inner
ear traumata. Results obtained in mice without the
major CaBPs present (CB-D28k, PV, CR) will hope-
fully shed more light on that topic (Pangrsic et al. ,
unpublished). Also, the absence of CB-D28k from
horizontal cells in the retina of CB-D28k-/- mice has
no apparent effect on the histology of the horizontal
cell layer, indicating that CB-D28k is not essential for
the structural maintenance of the differentiated retina
[158], but functional data have not yet been presented.
Transgenic mice used to study the “Ca2+
homeostasome” in renal and intestinal Ca2+
regulation
The availability of transgenic mouse models has
significantly extended our view on physiological
Ca2+ regulation in the intestine and kidney.Moreover,
it has revealed a tight interplay of molecules involved
in Ca2+ regulation, and this entity has been named the
Ca2+ signalsome [159] or also Ca2+ homeostasome
[21]; most often the terms are used in relation to
excitable cells such as muscle cells or neurons. The
best-studiedmolecules in the intestinal and renal Ca2+
regulation include the main apical Ca2+ channel
transient receptor potential vanilloid 5 (TRPV5;
previously known as ECaC1 [160]) and TRPV6
(previously known as CaT1) in the kidney and
intestine, respectively, and the CaBPs (CB-D28k,
CB-D9k) and the Na+/Ca2+ exchanger (NCX1) and
plasma membrane Ca2+-ATPase (PMCA1b) concen-
trated in the basolateral membrane. Results from KO
mice for CB-D28k, CB-D9k and other molecules
involved in the regulation of these are summarized
and the available transgenic strains are listed in
Table 1. Before discussing specific details, few general
conclusions can be drawn: (a) none of the knocked
down genes is absolutely essential for Ca2+ resorption
indicative of complex regulation with built-in redun-
dancy, (b) KO phenotypes under standard diets are
surprisingly mild, but become apparent upon exper-
imental manipulation, (c) some counter-intuitive
mouse phenotypes can only be explained when
compensatory or “homeostatic” mechanisms are
considered, and (d) the current data still do not to
allow for deducing the “precise” function of the
knocked-down proteins.
CB-D28k-/- mice show normal serum values for
ionized Ca2+, phosphate, PTH and urine Ca2+ excre-
tion (urine Ca2+/creatinine) [161]. Since compensa-
tion by CB-D9k was hypothesized to correct for the
loss of CB-D28k, and vitamin D receptor (VDR) KO
mice, characterized by hypocalcemia, secondary hy-
perparathyroidism, rickets and osteomalacia, have
significantly decreased CB-D9k levels (by 90%), the
role of the two CaBPs was investigated in VDR/CB-
D28k double-KO mice [161]. Alterations due to
changes in the Ca2+ regulation (increased urinary
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Ca2+ excretion, lower bone mineral density) are more
pronounced in the double-KOmice compared tomice
only deficient inVDR. The phenotype can be partially
normalized when mice are fed a high Ca2+, high
lactose diet, but skeletal abnormalities persist in the
double-KOmice, implicatingCB-D28k as also playing
an important role inmaintaining Ca2+ homeostasis. To
address the role of renal CB-D28k, double mutants
also deficient in TRPV5 (TRPV5-/-) were produced
[162]. Hypercalciuria is observed in double-KO mice
fed either a 0.02% or 2% Ca2+ diet, as in TRPV5-/-
mice, but not in mice lacking only CB-D28k. In
addition, in both strains without TRPV5, an equiv-
alent increase in renal CB-D9k expression as well as
an up-regulation of CB-D9k and TRPV6 in the
duodenum occurs, resulting in intestinal Ca2+ hyper-
absorption. None of these compensation mechanisms
are induced in CB-D28k-/- mice, indicating a “gate-
keeper function” of TRPV5, while the absence of CB-
D28k might possibly be compensated by up-regula-
tion of CB-D9k. A tight link between CB-D28k and
TRPV5 not only exists at the level of co-localization in
the same kidney epithelial cell population, but also at
the level of molecular interactions. At low intra-
cellular Ca2+, CB-D28k translocates to the apical
plasma membrane and by a direct interaction with
TRPV5 modulates its activity [135]. Rapid binding of
subplasmalemmal Ca2+ by CB-D28k prevents the
Ca2+-dependent inactivation of the TRPV5 channels,
thus allowing for a larger Ca2+ influx. A similar
mechanismhas already beenobserved in hippocampal
granule cells in CB-D28k-/- mice, albeit only func-
tionally, where the increased Ca2+-dependent inacti-
vation of voltage-dependent Ca2+ currents (ICa) led to
a diminished Ca2+ influx [163].
The first functional KO for CB-D9k (S100G) was
reported in 2006 [164]; in an embryonic stem (ES) cell
line, a frameshift deletion in murine S100G was
detected and these cells were used to produce trans-
genic mice. CB-D9k null-mutant mice are indistin-
guishable fromWT controls with respect to reproduc-
tion and also have normal serum Ca2+ levels, indicat-
ing that a functional S100Ggene is not required for the
most basic physiological functions including repro-
duction. Furthermore, intestinal Ca2+ absorption
under normal diet conditions in response to D3 is
not impaired, indicating that CB-D9k is not strictly
required for vitamin D-induced intestinal Ca2+ ab-
sorption [165]. Independently, a specifically targeted
S100G geneKOwas reported in 2007 by Jeung and co-
workers [166]. These mice also have no apparent
phenotype and the active intestinal Ca2+ transport is
normal. The authors proposed that homeostatic
mechanisms in the intestine, i.e. , up-regulation of
TRPV6 and PMCA1b during preweaning ,and addi-
tional renal homeostatic mechanisms in the adult
possibly lead to an almost undetectable phenotype
under standard diet conditions. In double mutants
additionally deficient for TRPV6, Ca2+ serum levels
are the same as in single mutant mice (CB-D9k-/-,
TRPV6-/-) or control WT mice [167]. In both groups
lacking TRPV6, serum PTH levels are increased 1.8-
fold, but more importantly, the increase in active
intestinal (duodenal) Ca2+ transport under low dietary
Ca2+ conditions is smaller in TRPV6-/- (2.9-fold), and
even smaller in the double mutants (2.1-fold) com-
pared to CB-D9k-/- and WT mice: 4.1- and 3.9-fold,
respectively. Administration of D3 to vitamin D-
deficient mice of all four groups led to a significant
increase (40–100%) in duodenal Ca2+ transport. This
hints that eliminating the previously thought “essen-
tial components” in intestinal absorption (TRPV6 and
CB-D9k) only reduces, but not eliminates vitamin D-
induced active intestinal Ca2+ transport strongly
suggestive of additional vitaminD-dependent absorp-
tion mechanisms.
The modulation of the Ca2+ homeostasome by dietary
Ca2+ andD3was also investigated inmice deficient for
25-hydroxyvitamin D3–1a-hydroxylase (1a-
OHase-/- mice) [168]. The observed decrease in
serum Ca2+ levels is the likely result of diminished
levels of TRPV5, CB-D9k, CB-D28k and NCX1.
Feeding mice with a Ca2+-enriched diet or D3
repletion normalizes levels of proteins involved in
Ca2+ resorption and also serum Ca2+; yet Ca2+ enrich-
ment alone is not sufficient to normalize CB-D9k
expression. Nonetheless, serum Ca2+ levels are also
normal under these conditions, as in the CB-D9k-/-
mice, supporting the hypothesis of functional redun-
dancy. In a model of Crohns disease, TNF(Del-
taARE/+) mice are characterized by an approximate-
ly 50% decrease in D3 that accompanies with
decreased protein levels of duodenal CB-D9k and
renal CB-D28k; at the level of mRNA, TRPV6 and
PMCA1b (duodenum) and renal TRPV5 and NCX1
mRNAare also down-regulated [169]. The unchanged
serum Ca2+ levels in these animals can only be
maintained by a Ca2+ loss from bone (reduced
trabecular and cortical bone thickness and volume),
a likely compensation mechanism to cope with the
general Ca2+ shortage in these mice. Also pharmaco-
logical interventions with diuretics (chlorothiazide,
furosemide) affect the expression of the above
molecules involved in renal Ca2+ regulation (details
can be found in [112]). Although much has been
learned from the various transgenic mouse models,
the results indicate that other, yet-undiscovered
mechanisms must be present to additionally regulate
intestinal and renal Ca2+ resorption.
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Calretinin
General aspects of CR
CR consists of 269–271 amino acids (depending on
the species), organized in six EF-hand domains, five of
which are able to bind Ca2+ ions [108, 170, 171].
Currently, no structural data (X-ray or NMR) is
available for full-length CR, but NMR results were
published on theN-terminal 100 amino acids of rat CR
consisting of EF-hand domains 1 and 2 [172]. The two
domains form a relatively tight structure, while the
linker region between domains is exposed to solvent
and accessible for proteolytic enzymes. Limited pro-
teolysis studies on the full-length protein and thiol
reactivity experiments suggest that the C terminus of
CR is in relatively close proximity to site 1 [108]. This
is also the case for CB-D28k (Fig. 2), suggesting that
the overall structure of the two proteins is likely very
similar. The fact that the fluorescence of the hydro-
phobic probe 2-p-toluidinylnaphtalene-6-sulfonate is
markedly enhanced by CR already in the absence of
Ca2+ and even further increased by Ca2+ binding hints
that CRmight also belong to the ”sensor”-type family
of CaBPs. This proposition is also based on additional
in vitro studies on the properties of CR (reviewed in
[173]).
Flow dialysis experiments showed that human CR
contains four Ca2+-binding sites with positive cooper-
ativity (nH =1.3) that are half-filled by Ca
2+ ions at
1.5 mM Ca2+ and a fifth site with much lower affinity
(intrinsic dissociation constant KD of 0.5 mM; [108]).
An even higher cooperativity (nH=1.9) is observed for
chick CR [171]. Themost detailed in vitro study on the
binding parameters of CRwas carried out by applying
the samemethodology, i.e. , release of cagedCa2+ from
DM-nitrophen [174], as used before for the determi-
nation of the binding properties of CB-D28k [125].
The prior determination of the kinetic properties of
DM-nitrophen, i.e. , its binding to Ca2+ andMg2+ [175]
was a requirement for the accurate modeling of CR.
Faas and co-workers [174] developed a new mathe-
matical model to determine the dynamic properties of
cooperative binding to gain a better understanding of
the physiological implications of cooperativity. In line
with previous experiments, CR ismodeled as a protein
with four cooperative binding sites and one independ-
ent binding site, and results are summarized in
Table 2. In themodel, the cooperative pairs of binding
sites influence each other in an allosteric manner.
Within one pair, each binding site is in a T (tense) state
with a low affinity and slow binding rates, if the other
binding site is unoccupied, whereas it is in an R
(relaxed) state with a high affinity and fast binding
rates, if the other binding site is occupied. This causes
the association rate of Ca2+with CR to speed up as the
free Ca2+ concentration increases from cytoplasmic
resting conditions (~100 nM) to approximately 1 mM.
Thus, the Ca2+ -buffering speed of CR strongly
depends on the prevailing Ca2+ concentration prior
to a perturbation and the functional consequences of
the unexpected Ca2+-binding properties are discussed
below.
Functional aspects of CR
After its initial characterization in 1987 [8], most
papers on CR focused on the question where and
when the protein is expressed in (a) different species,
(b) different tissues, (c) different cell types, sometimes
even subcellular compartments, and (d) in certain
pathological conditions (e.g., [176]). Results from
these earlier studies are, at least in part, summarized in
[77, 78, 177]. Indirectly, a protective role against
excitotoxicity was inferred from the finding that
cortical CR-expressing neurons are more resistant
against glutamate toxicity than the general neuron
population [178] and that CR-immunoreactive neu-
rons are resistant to b-amyloid toxicity in vitro [179],
but no experimental proof was presented that CR is
directly involved in the protective mechanism. Direct
experimental manipulation of CR expression in CR-
expressing colon cancer cells revealed that down-
regulation by antisense oligos leads to a blockage of
the cell cycle and an increase in apoptosis [180]. CR
overexpression in PC12 cells provides no protection
against Ca2+ overload induced by Ca2+ ionophore
treatment or trophic factor deprivation [181].Also the
presence of CR at an estimated concentration of 1 mM
in transfected glioma C6 cells does not significantly
affect Ca2+ transients induced by ionomycin, ADP or
thapsigargin [182]. This is not very surprising based on
the later acquired knowledge that CR concentrations
within neurons are likely to be in the order of tens of
micromolar [53, 183] and that fast buffers mainly
affect short-lived Ca2+ transients typically seen after
AP induction (see below).
The next major step in elucidating the functions of CR
was the generation of CR-null-mutant mice (CR-/-;
systematic name: Calb2tm1Map; Table 1) in 1997 [184],
where impaired long-term potentiation (LTP) in the
hippocampus was the first reported alteration. Basal
synaptic transmission between the perforant pathway
and granule cells, and also at the Schaffer commissural
input to CA1 pyramidal neurons is unchanged. Yet
tetanic stimulation of the perforant pathway increases
the excitatory drive from CR-deficient mossy cells
onto hilar interneurons, and the excess of GABA
release onto dentate granule cells is thought to cause
the inhibition of LTP induction. This hypothesis is
based on the fact that LTP impairment can be
prevented by the GABA blocker bicuculline. Unlike
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most other CaBP KO mice, where the heterozygous
animals rarely show a phenotype, impaired LTP is also
seen in CR+/- mice indicating that half of the CR
expression levels compared to WT control mice is not
sufficient to sustain normal LTP [185]. The rather
uniform expression of CR in cerebellar granule cells
and the stereotypic organization of the cerebellum
have made this the prime site for the in vivo
investigation of the physiological function of CR.
Granule cells provide the major excitatory input onto
Purkinje cells via the parallel fibers, thus allowing the
role of CR in presynaptic terminals to be addressed,
whereas stimulation of mossy fibers contacting the
soma of granule cells is expected to yield information
on the role of postsynaptic CR. Impairment of motor
coordination in CR-/- mice is linked to altered Ca2+
homeostasis in Purkinje cells, indirectly supported by
the increased Ca2+ saturation of CB-D28k in these
cells [186].As inCB-D28k-/- and PV-/-mice, the firing
properties of Purkinje cells are altered in alert CR-/-
mice. Themost notable changes include an increase in
the simple spike firing rate, a shortening of the
complex spike duration, and a shortening of the
spike pause [186]. At the network level, these altered
firing properties likely lead to the emergence of 160-
Hz oscillations [73], not observed in WT mice. The
similarity of the oscillations inmice deficient for either
PV, CB-D28k or CR indicates an effect at the system
level. Thus, pharmacological blocking of (a) gap
junctions between interneurons, (b) the N-methyl-D-
aspartate receptors, or (c) the GABAA receptors by
gabazine reversibly attenuates these oscillations. This
indicates that oscillations emerge via a mechanism
that synchronizes assemblies of Purkinje cells (medi-
ated by parallel fiber excitation) and the network of
chemically coupled molecular layer interneurons
(stellate/basket cells), although the putative involve-
ment of networking by recurrent Purkinje cell collat-
erals was recently emphasized [187]. Granule cells of
CR-/- mice show faster action potentials and, under
conditions generating repetitive spike discharges,
show enhanced frequency increase with injected
currents [183]. The effect can be reversed in the
presence of the fast buffer BAPTA (150 mM) in the
recording pipette, arguing that CR under these con-
ditions functions as a “fast” Ca2+ buffer, but this is not
the only mode of how CRmight work inside cells (see
below). Further support that the CR deficiency in
granule cells is responsible for the observed 160-Hz
oscillations comes from the findings on CR “rescue”
mice, where CR is selectively re-expressed in granule
cells of otherwise CR-deficient mice [188] using the
GABAA receptor a6 promoter [189] to drive CR
expression selectively in this neuron population. In
alert “rescue” mice, normal granule cell excitability
and Purkinje cell firing is restored resulting in neither
160-Hz oscillations nor impairment in motor co-
ordination. Thus, subtle disturbances in the modula-
tion of Ca2+ transients in the subpopulation of neurons
expressing CR [73], CB-D28k or PV [76] in the
cerebellum impairs cerebellar functions, indicating
that Ca2+ homeostasis is crucial for the coding and
storage of information in the cerebellum.
CR may function as a “fast” and as a “slow” buffer
That CR also works as a “slow” Ca2+ buffer was
gleaned from experiments with Xenopus oocytes.
Direct injection or cDNA-mediated overexpression
of the “slow” buffer PV induces elementary Ca2+
release events by Ca2+-induced Ca2+ release (CICR)
resulting in Ca2+ puffs, which are elicited fromdiscrete
clusters of inositol 1,4,5 triphosphate receptors (IP3R)
at low concentrations of IP3 [190]. Similar Ca
2+ puff
activity also occurs after EGTA injection, but not in
the presence of the fast buffer CB-D28k. In general,
fast buffers such as BAPTA blunt the amplitudes of
Ca2+ responses and at the same time promote the
“globalization” of spatially uniformCa2+ signals [191].
Thus, the distinct kinetic properties of Ca2+ buffers
strongly influence the time course and spatial distri-
bution of IP3-evoked Ca
2+ signals. An unexpected
finding was observed with CR, based on previous
experimental results showing that CRbehaves like the
fast buffer BAPTA in modifying presynaptic Ca2+
signaling in frog saccular hair cells [192]. In Xenopus
oocytes at low IP3 release conditions resulting in only
small Ca2+ transients, CR induces Ca2+ puffs, which
are never observed with BAPTA, but are typical for
“slow” Ca2+ buffers. This dual behavior results from
the particular Ca2+-binding properties of CR, in
particular the strong cooperativity between the paired
binding sites (1–2 and 3–4) discussed above. Small
Ca2+ elevations will only activate the two cooperative
binding sites in the T state that are characterized by a
rather low affinity (28 mM) and a slow on-rate
(1.8106 M-1 s-1) [174]. The effects of CR on a train
of ten dendritic Ca2+ transients were modeled and
compared to BAPTA (fast) and EGTA (slow) (Fig. 3;
kindly provided by G. Faas, UCLA, for details on the
model, see legend). In the model, Ca2+ channels open
for 10 ms at 50-ms intervals (20 Hz). From a resting
[Ca2+]i of 100 nM, in the absence of buffers (dashed
line) the peak maximum reaches ~10 mM. By adding
30 mM CR, i.e. , 150 mM of Ca2+-binding sites, the
initial peak amplitude is reduced to ~3 mM (black
line), but due to continuous sequestering and releas-
ing Ca2+ during the following series, [Ca2+]i does not
return to the initial level of 100 nM, but slowly rises to
~0.8–1 mM (inset). When [Ca2+]i is still relatively low
before the next Ca2+ influx (<500 nM, area A), CR
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acts as a slow buffer comparable to EGTA (150 mM,
red line). More unoccupied Ca2+-binding sites of CR
are in the fast R state at the end of the train, when the
minimal Ca2+ concentration is >700 nM before the
next Ca2+ pulse (area B). This leads to a more
BAPTA-like behavior (blue line) of CR. Thus, the
non-linear property of CR causes the shapes of
individual transients to remaining practically the
same throughout the series (peak maximum ~3 mM),
in contrast to the effects induced by either EGTA or
BAPTA. The slow buffer EGTA is responsible for the
fast initial decay in [Ca2+]i during the first transient,
but the accumulation of Ca2+-bound EGTA (“buffer
saturation”) leads to a reduced buffering capacity
later on, resulting in higher peak amplitudes late in the
series (red trace in area B). On the other hand,
BAPTAs fast binding kinetics almost completely
abolish the Ca2+ elevation during the first Ca2+ influx
and only as the buffering capacity decreases due to
BAPTAgetting Ca2+-loaded, does the peak amplitude
reach values similar to those in the presence of CR
(compare blue and black traces in area B). However,
typically for a fast buffer, BAPTA considerably slows
down the [Ca2+]i decay by acting as a Ca
2+ source, a
concept initially elucidated in the early 90 s [193–
195].
Regulation of CR expression
Very little is known about the physiological regulation
of CR expression. In several reports altered expres-
sion due to various manipulations have been reported
and include down- or up-regulation of CR [196–201].
In the mouse CR gene (CALB2), upstream promoter
and enhancer elements including TATA and CAAT
boxes show considerable sequence homology to
human (CALB2) upstreamelements [202].Aminimal
element ending at –95 bp upstream of the transcrip-
tion start site confers neuron specificity and the rat
–115/–71 CALB2 promoter region contains a binding
site for a factor present in brain nuclear extracts (e.g. ,
from cerebellar granule neurons) [203]. This AP2-like
element located between –90 and –80 bp appears
essential for the neuron-specific activity of the
CALB2 promoter. In contrast, this element appears
to be non-functional in CR-expressing colon cancer
andmesothelioma cells, indicating that CR expression
Figure 3. Effect of Ca2+ buffers on dendritic Ca2+ signals (simulations with Berkeley Madonna using a single compartment model; for
additional details, see [174]). In a cylinder-shaped dendritic compartment (r =1 mm, l =10 mm), Ca2+ channels open ten times for 10 ms
every 50 ms (20 Hz). The current of 10 pA corresponds to opening of ~3–5 channels, depending on the channel type and extracellular
[Ca2+]. Themembrane contains Ca2+ pumps (Km=3 mM, vmax=50 pmol cm
–2 s-1) [70, 229] that maintain [Ca2+]i at 100 nM. In the absence of
buffers, the peak amplitude is ~10 mM (dashed line) and drops to 100 nM between transients. Addition of CR (30 mM, corresponding to
150 mM Ca2+-binding sites, black line) reduces the amplitude to ~3 mM during the first peak with little variation during consecutive
transients. The effect of equivalent amounts (150 mM) of EGTA (red line, KD 70 nM [125], kon 10
7 M-1 s-1) and BAPTA (blue line, KD
160 nM, kon 210
8 M-1 s-1) on the shape of Ca2+ transients is quite different. Although early transients (area A) look similar in the presence
of CR andEGTA, later on with EGTA the amplitude starts to increase (area B). BAPTA almost completely abrogates the peak amplitude
in area A and only in the last transients of the train, the Ca2+ influx exceeds BAPTAs buffering capacity allowing amplitudes to reaching
similar values as in the case of CR (area B). The late phase of the [Ca2+ ]i decay after the tenth transient is shown at higher magnification in
the inset reporting the residual Ca2+ in the presence of the three buffers compared to the situation pertaining in the absence of added
buffers. As a result of the non-linear binding properties of CR [174], the amplitudes in the presence of CR remain almost constant
throughout the 10 Ca2+ transients (for mechanistic details, see section CR may function as a “fast” and as a “slow” buffer).
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in neurons and cancer cells is regulated via different
mechanisms [204]. Specifically in colon cancer cells,
addition of butyrate, an enhancer of differentiation,
down-regulates CR expression [200]. In several colon
cancer cell lines and primary colon tumor tissue, two
additional CR transcripts coding for truncated ver-
sions of CR are present [205]. The deletion of exons 8
and 9 or of exon 8 only of the human CALB2mRNA,
leads to a frame shift and premature stop codons,
resulting in proteins named CR-22k (192 amino acids,
accession no. NP_009019) and CR-20k (179 amino
acids, accession no. NP_009018), respectively. So far,
these splice variants have only been detected in
transformed cells derived from colon [206] or meso-
thelioma tissue [207], and little is known about the
regulation of these transcripts. Nonetheless, the aber-
rant CR expression is most helpful in identifying
mesotheliomas, a tumor of the serosal lining of the
body cavities that is often difficult to differentiate
from lung carcinomas [208, 209], for example.
During development, CR expression and also intra-
cellular localization are regulated. In brainstem audi-
tory neurons in the chick nucleus magnocellularis, CR
immunoreactivity changes from being diffusely dis-
persed throughout the cytoplasm to being highly
concentrated beneath the plasma membrane [210].
This change coincides with the onset of spontaneous
activity, synaptic transmission, and synapse refine-
ment in nucleus magnocellularis. It was hypothesized
that localization of CR beneath the plasmamembrane
is an adaptation to spatially restrict the Ca2+ influxes
(see also next section).
The intracellular Ca2+ homeostasome
To use variations in [Ca2+]i as an intracellular signal,
cells must have a finely tunable system regulating
[Ca2+]i most accurately in time and space. An increase
in [Ca2+]i may be brought about by opening of Ca
2+
channels in the plasma membrane or by a release of
Ca2+ from internal stores, most importantly from the
endoplasmic reticulum (ER). In the cytosol the signal
is thenmodulated by immobile ormobile intracellular
Ca2+ buffers, in particular CaBPs, and at the end the
initial situation is restored by either Ca2+ extrusion by
plasma membrane Ca2+ pumps (PMCA), the Na+/
Ca2+ exchanger (NCX) or by uptake into organelles
including the ER, mitochondria and possibly also
peroxisomes [211]. How does a particular cell “know”
howmany andwhich type of the different components
of the Ca2+ homeostasome are necessary, and how
does a cell cope when one or several of these
components are missing (e.g., by targeted ablation)
or functionally compromised (e.g., in genetic diseas-
es)? It is clear that Ca2+ itself is an important regulator
of gene expression as evidenced for example in
cultured cerebellar granule cells, where neuronal
survival is dependent on Ca2+ influx induced by
membrane depolarization. This leads to the up-
regulation of IP3R and PMCAs, and in parallel, to
the down-regulation of one splicing variant of the
isoform PMCA4 and one of the Na+/Ca2+ exchangers
of the plasma membrane (NCX2) [212]. Thus, a cell
has an extensive “Ca2+-signaling toolkit” to precisely
shape the Ca2+ signaling system also involved in
controlling the expression of its own components (for
a review, see [159]).
Findings on the Ca2+ homeostasome where CaBPs are
involved are briefly summarized here. In essentially
all reports on CaBP KO mice, the absence of a
particular CaBP is not compensated by another EF-
hand family member normally not expressed in this
cell type, e.g. , the subset of PV-immunoreactive (-ir)
interneurons in PV-/- mice do neither express CB-
D28k, CB-D9k nor CR [72]; correspondingly, the
same holds true for the CR-ir or the CB-D28k-ir
neurons. This suggests that neurons once committed
to express a particular CaBP, are either incapable of
turning on the expression of another EF-hand family
member with “similar” Ca2+-binding properties or
that the distinct properties (affinities, kinetics, mobi-
lity) of any other CaBP would not suffice to restore
“normal” Ca2+ homeostasis [64]. Homeostatic mech-
anisms observed in the brain of CaBP-KO mice
include alterations in the spinemorphology (increased
length and volume) of Purkinje cells selectively in CB-
D28k-/- mice, but not in PV-/- animals [213]. Yet, in
the soma of PV-/- Purkinje cells, the volume of
mitochondria, organelles involved in Ca2+ sequestra-
tion and acting as a transient Ca2+ store [214] is
selectively increased by about 40% in a narrow zone
underneath the plasma membrane, while the density
of perinuclear mitochondria is unchanged [215]. At
the same time the subplasmalemmal ER compart-
ment is also decreased. All these alterations are not
present in CB-D28k-/- Purkinje cells. The inverse
relationship between mitochondrial volume and PV
expression is also seen in fast-twitch muscle fibers
[216] and, interestingly, the mechanism also functions
the other way round: ectopic expression of PV in
striatal neurons normally not expressing PVdecreases
themitochondrial volumeby almost 50% [217], which
accounts for the heightened excitotoxic injury pro-
voked by a local injection of ibotenic acid into this
transgenic mouse line named Thy-PV mice [218].
Adaptive changes involving CaBPs are also seen in
Purkinje cells of leaner [tg(la)] mice characterized by
a mutation in the voltage-activated Ca2+ channel
a(1A) subunit, the pore-forming subunit of P/Q-type
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Ca2+ channels. The severely reduced Ca2+ channel
function is “compensated” by a diminished Ca2+
buffering/uptake capacity due to decreased Ca2+
uptake by the ER and a reduction in PV and CB-
D28k expression ([219], for a review, see [220]). Such
homeostatic mechanisms involving Ca2+ channels and
Ca2+ buffering are also functional during ageing as
observed in basal forebrain neurons [221]. CaBPs also
directly modulate the activity of Ca2+ channels,
including the N-, L- and P/Q-type Ca2+ channels.
They are involved in both Ca2+-dependent inactiva-
tion and facilitation, and the best-studied example is
CaMmodulating L-type Ca2+ channels [222] as well as
P/Q-type channels [223]. Both PVand CB-D28k play
a role in modulating Ca2+-dependent inactivation, but
not facilitation [224] and, interestingly, the two
physiological Ca2+ buffers affect P/Q-type channel
function differently from the synthetic buffers EGTA
and BAPTA, often presumed to substitute for “real”
CaBPs. The Ca2+-dependent inactivation of P/Q-type
channel is assumed to depend on Ca2+ microdomains
surrounding the Ca2+ channels in the plasma mem-
brane and these microdomains are likely to be
affected differently by the various Ca2+ buffers. This
in turn specifically affect the inactivation properties of
the Ca2+ channels. Alterations in Ca2+ extrusion
systems by plasma membrane ATPases (PMCA)
also modulate the Ca2+ homeostasome. A mutation
in PMCA2 expressed at particularly high levels in
Purkinje neurons is correlated with reduced Ca2+
influx due to the down-regulation of voltage-gated
Ca2+ channels [225]. In PMCA2-/- mice exhibiting
ataxia, expression levels of metabotropic glutamate
receptor 1 and of inositol 1,4,5-triphosphate receptor
type 1 responsible for the Ca2+ release fromER stores
are down-regulated [226]. In Purkinje cells from CB-
D28k-/-PV-/- mice, an increase in Ca2+ extrusion
mechanisms was postulated, since the decay of
dendritic Ca2+ signals could only be accurately fitted
when using a twofold higher extrusion rate compared
to the rates sufficient to model the transients in PV-/-
andWTPurkinje cells [70]. Yet themolecular identity
(PMCA, NCX, intracellular stores) leading to the
increased [Ca2+]i decay was not investigated in this
study.
Conclusions
Studies on the various CaBP-KO mice have revealed
that each Ca2+ buffer/sensor has distinct functions,
which agreewith its specific Ca2+-buffering properties.
Ablation of a CaBP does not induce the apparently
obvious compensatory mechanism, i.e. , the up-regu-
lation of a CaBP with properties most closely resem-
bling the eliminated one, but leads to very specific
adaptations at the level of other components of the
Ca2+-signaling toolkit and morphological changes. In
the brain or in the systems involved in Ca2+ resorption
(intestine, kidney), the adaptive changes are not
limited to the population of cells from which a CaBP
has been removed, but includes changes in other cell
populations functionally connected to the altered
(impaired) ones. Thus, CaBP-deficient cells make use
of the components of the Ca2+-signaling toolkit [159]
to attempt to restore the situation pertaining in
unaffected cells; yet the Ca2+ homeostasome is even
more far reaching, also remodeling Ca2+-signaling
components in cells not directly affected by the
absence of the ablated CaBP.
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